Can We Miss Pigmented Lesions in Psoriasis Patients?

You may not qualify if:

• Serum creatinine \> 3.0 mg/dL (265 micromoles/L)
• Serum potassium \< 3.5 mmol/L or \> 5.5 mmol/L
• Serum alanine aminotransferase or Aspartate transaminase \> 3 times the upper limit of normal for the Lab
• Platelet count \< 100,000/mm3
• White blood cell count \< 3,000 cells/mm3
• Hemoglobin, hematocrit, or red blood cell count outside 30% of the upper or lower limits of normal for the Lab
• Systemic therapy use (e.g. phototherapy, methotrexate, cyclosporine, oral steroids, systemic biologics) within the previous 4 weeks
• Topical therapy use (e.g. topical steroids, vitamin D derivatives) within the previous 2 weeks
• Subject is currently enrolled in another investigational device or drug trial(s), or subject has received other investigational agent(s) within 28 days of baseline visit.
• Subjects who have known hypersensitivity to Enbrel or any of its components or who is known to have antibodies to etanercept
• Prior or concurrent cyclophosphamide therapy
• Concurrent sulfasalazine therapy
• Known Human immunodeficiency virus-positive status or known history of any other immunosuppressing disease
• Active severe infections within 4 weeks before screening visit, or between the screening and baseline visits
• Untreated Lyme disease
• +7 more criteria